Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Cancer Statistics, 2017.

Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712

Inferring tumour purity and stromal and immune cell admixture from expression data

Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645

The <tt>sva</tt> package for removing batch effects and other unwanted variation in high-throughput experiments

Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645

The consensus molecular subtypes of colorectal cancer

Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

Becht, É., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Sèlves, J., Laurent‐Puig, P., Sautès‐Fridman, C., Fridman, W. H., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,677

Genomic analyses identify molecular subtypes of pancreatic cancer

Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Additional file 11 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665348

Additional file 20 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777905

Additional file 5 of Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586798

Additional file 21 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777908

Additional file 9 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665342

Additional file 3 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665324

Additional file 10 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777875

Additional file 3 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777851

Additional file 6 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665333

Additional file 6 of Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586801

Additional file 16 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777893

Additional file 4 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777854

Additional file 15 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777890

Additional file 14 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777887

Additional file 1 of Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586786

Additional file 24 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777917

Additional file 1 of DECONbench: a benchmarking platform dedicated to deconvolution methods for tumor heterogeneity quantification

Decamps, C., Arnaud, A., Petitprez, F., Ayadi, M., Baurès, A., Armenoult, L., Escalera, S., Guyon, I., Nicolle, R., Tomasini, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16726873

Additional file 11 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777878

Additional file 8 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665339

Additional file 5 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665330

Additional file 5 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777857

Additional file 3 of Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586792

Additional file 8 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777866

Additional file 6 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777860

Additional file 13 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777884

Additional file 18 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777899

Additional file 2 of Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586789

Additional file 7 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665336

Additional file 10 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665345

Additional file 23 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777914

Additional file 17 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777896

Additional file 1 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665318

Additional file 7 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777863

Additional file 26 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777923

Additional file 4 of Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma

Yang, J., Lin, P., Yang, M., Liu, W., Fu, X., Liu, D., Tao, L., Huo, Y., Zhang, J., Hua, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520764

Additional file 13 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665354

Additional file 19 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777902

Additional file 4 of Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586795

Additional file 1 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777845

Additional file 25 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777920

Additional file 4 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment

Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665327

Additional file 22 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777911

Additional file 27 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777926

The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant therapy

Wang, H., Li, Y., Tang, S., Li, Y., Zhang, Y., Yin, X., He, J., Zhu, Y., Zhang, Y., Shi, X., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218252

Benefits of Fucoxanthin in the Prevention of Chronic Diseases

Terasaki, M. (2026) · Springer eBooks · doi:10.1007/978-3-032-05253-7_11

Biomarker Identification in Pancreatic Cancer Through Concordant Differential Expression and Interpretable Machine Learning AnalysesPreprint

Escalante, S. M., Aladid, R. L., Muñoz-Tovar, R., López-Herrero, M., Selles, A. N., Garmendia, L., Lillo, C. P., Fossati, M., & Parente, P. (2026) · medRxiv · doi:10.64898/2026.02.13.26346263

Decoding the Integrated Stress Response of Pancreatic Cancer: Identifying a Serine‐dependent Tumor Subset Under Metabolic Relationships With CAFs.

Shin, S., Liauzun, M., Solorzano, J., Bras, M. L., Jean, C., Fourneaux, B., Dore, M., Fevrier, L., Belhabib, I., Brunel, A., et al. (2026) · Advanced Science · doi:10.1002/advs.202515740

Targeting mitochondrial metabolism in pancreatic cancer

Reyes‐Castellanos, G. (2021) · theses.fr (ABES) · doi:10.70675/461953f3z886ez4342za1e2z84c44a9fcaa6

Translatome-based classification of pancreatic cancer

Shin, S. (2020) · theses.fr (ABES) · doi:10.70675/09efa5edz6f6ez4463z90eaz76d4c6c23a9d

Study of the impact of nucleolin targeting on pancreatic ductal adenocarcinoma immune microenvironment

Ponzo, M. (2020) · theses.fr (ABES) · doi:10.70675/05815fd1z5314z4734z8240zd1a40c5a9bdf

Exploring PI3K signalling dynamics in pancreatic cancer

Delgado, C. F. R. (2020) · theses.fr (ABES) · doi:10.70675/6df9a059zc3f1z4997z9de2z34a1d24dfbeb

Impact du dialogue entre microenvironnement et cellules cancéreuses dans l'adénocarcinome canalaire pancréatique

Nigri, J. (2020) · theses.fr (ABES) · doi:10.70675/8e941da5z4553z4ca3zaf8az9ac2c39c788a

Utilisation des gènes de glycosyltransférases pour stratifier les patients atteints d'adénocarcinome pancréatique : identification d'une glyco-signature pronostique et biomarqueurs associés

Abd-El-Halim, Y. M. (2021) · theses.fr (ABES) · doi:10.70675/7a02077czfc19z45f2z92f0ze2f11ebce9fd

Characterisation of SG33 Myxoma virus replication and oncolytic activity in pancreatic cancer models

Quillien, L. (2021) · theses.fr (ABES) · doi:10.70675/eadfa28azee41z4b56z88f3zc40b7ff9f900

Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identificationPreprint

Semaan, K., Eid, M., Vasseur, D., Gulati, G. S., Lima, C. F. P., Ibrahim, É., Seo, J.-H., Canniff, J., Savignano, H., Jordan, A. C., et al. (2026) · medRxiv · doi:10.64898/2026.04.02.26349987 · Cited by 1

Etude de l’influence du TGF-β sur les sous-populations de fibroblastes associés au cancer et leur implication pronostique dans les cancers du pancréas

Vienot, A. (2021) · theses.fr (ABES) · doi:10.70675/25d883b4z5eadz4f1bz93f0zcfa886c08e78

Identification et ciblage de dialogues tumeur-stroma impliqués dans l'agressivité de l'adénocarcinome canalaire pancréatique

Brunel, A. (2022) · theses.fr (ABES) · doi:10.70675/4f9e08fez29b2z4a0dzabf6z424c6decb590

Targeting mitochondrial and redox metabolism to prevent relapse in pancreatic cancer

Hadi, N. A. (2022) · theses.fr (ABES) · doi:10.70675/de0db041z7be5z4ee3z8a2cz7ca2e21ede31

The impact of the acidic tumor microenvironment on ion channel expression and regulation, in the progression of pancreatic ductal adenocarcinoma

Schnipper, J. (2022) · theses.fr (ABES) · doi:10.70675/f216ab05z34c2z4a92z9ebdzca69010c52d8

Identification de biomarqueurs pronostiques des tumeurs du carrefour bilio-pancréatique

Robin, F. (2022) · doi:10.70675/1797b136z45cdz4d34z8c8ez13e32fea4cc6

Role of the stromal microenvironment in PDAC and resistance to therapies

Ode, A. (2024) · theses.fr (ABES) · doi:10.70675/0452e0e9z98e8z47d9za007zd4b472926aab

Stroma-nerve axis in pancreatic ductal adenocarcinoma: Bidirectional regulatory mechanisms and clinical translation hypothesis

Yu, Y.-N., Jin, S.-Q., Lu, Y.-T., & Han, L.-Z. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i4.117197

Targeting pancreatic cancer with combined inhibition of EGFR and RAF

Brandstetter, J., Goldstein, L., Schreiber, T., Palme, R., Lindner, T., Joksch, M., Krause, B., Vollmar, B., & Kumstel, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347843

A tumor microenvironment integrated (TMI) staging system for pancreatic ductal adenocarcinoma based on cancer-associated fibroblast and molecular consensus signatures

Yeo, S. J., Ian Tate Ek Ern, S. I. M., Tay, H. Y., Tai, D., Shi, R., & Chan, J. H. (2026) · Discover Oncology · doi:10.1007/s12672-026-05091-0

Pancreatic multi structure segmentation on CT using transformer and deep learning approaches

An, C., Yang, B., Zhang, C., Mu, X., Yun, Y., Yang, G., Peng, C., & Xu, Z. (2026) · Discover Oncology · doi:10.1007/s12672-026-04823-6

Extra-lineage tissue programs define the transcription states of human pancreatic cancerPreprint

Ge, S., Tonon, P., Xu, J., Jang, G.-H., Nowlan, F., Min, J., Ng, K., Figueroa, E. F., Zhang, A. X. W., Chan‐Seng‐Yue, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.29.721655 · Cited by 1

Cancer‐Associated Fibroblasts: Central Players in the Plastic Pancreatic Cancer Microenvironment and Therapeutic Targeting

Qin, Z., Ma, J., Jü, R., & Guo, L. (2026) · Organ medicine. · doi:10.1002/orm2.70044

Emerging concepts, hot topics, and open questions in today’s pancreatic cancer research

Keber, C. U., Schmitt, M., Visekruna, A., Brichkina, A. I., von Strandmann, E. P., Bartsch, J. W., Huber, M., Bauer, U., Gress, T. M., & Lauth, M. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189614

Integrative multi-omics analysis identifies a core ferroptosis signature and validates resveratrol as a novel inducer in pancreatic cancer

Diao, W., & Liu, F. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05385-8

Molecular Subtypes of Pancreatic Cancer: A Review of the Literature

Wnuk, J. S., Skowron, W., Długaszek, A., Sadurska, J., Pietrzyński, Ł., Kabut, J., & Gisterek, I. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050502

Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo

Khan, M. A., Chang, J., Song, Y., Shetty, A. C., Nguyen, T., Waters, D. N., Chowdhury, D. D., Simms, E. R., Chan, A., Tseng, H. W., et al. (2026) · Lab Animal · doi:10.1038/s41684-026-01729-2

Luminal–basal stratification of the native human pancreatic duct is differentially represented in pancreatic cancers

den Bossche, J.-L. V., der Vliet, M. V., Michiels, E., Senar, O. A., Lint, S. V., Madran, Z., Coolens, K., Brons, J., Nacher, M., Arsenijevic, T., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337970 · Cited by 1

Modeling pancreatic cancer tumor stroma co-evolution in an in ovo modelPreprint

Ranjan, R. A., Ravichandra, A., Putze, P., Chernysheva, A., Wirth, J., Lucarelli, D., Ng, W. Y., Pavlovska, O., Sibanda, K. S., Leipe, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.26.734719

Integrative single-cell and spatial transcriptomic approaches to decipher the tumor microenvironment and therapeutic resistance in pancreatic cancer

Luo, M., Shen, F., Xu, W., Corpe, C. P., & Wang, J. (2026) · Cancer Biology & Therapy · doi:10.1080/15384047.2026.2699508

Prognostic and predictive values of transcriptomic signatures in metastatic pancreatic cancer: A biomarker analysis of three French multicenter prospective randomized controlled phase 2 trials (Prodige35, Prodige37 and AFUGEM)

Zhao, S., Nicolle, R., Taı̈eb, J., Dahan, L., Abdallah, R., Bouché, O., Desrame, J., Phelip, J., Evesque, L., Akouz, F. K., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218745

Spatially resolved tissue architecture and computational pathology in pancreatic cancer

Bae, S.-W., Tsirigos, A., Min, J., & Maitra, A. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01782-4

A reproducible epithelial transcriptional state combines interferon-associated and secretory programs in pancreatic ductal adenocarcinoma

Mi, X., Wu, S., & Xiao, L. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1907806

MTAP-Deficiency Identifies a Myofibroblastic and Immune-Attenuated Tumor Microenvironment Subtype in Pancreatic Ductal AdenocarcinomaPreprint

Karlbauer, J., Knipper, K., Bedau, T., Schloesser, H., Thomas, M., Buettner, R., Bruns, C., Popp, F., Lyu, S. I., & Quaas, A. (2026) · Research Square · doi:10.21203/rs.3.rs-10656530/v1

The Classical–Basal Spectrum in Pancreatic Ductal Adenocarcinoma: A Developmental Framework for Tumour Cell Plasticity and Clinical Translation

Khan, I., Belhaj, A., Gemini, A., Ibis, K. A., Darsif, N., Rouani, N., Vanlander, A., & Messaoudi, N. (2026) · Cancers · doi:10.3390/cancers18172733

A serpin–myeloid axis in pancreatic cancer heterogeneity and immune evasion

Falcomatà, C., Schaefer, M. M., Singh, B., Chhamalwan, D., Tepper, A., Nielsen, S. R., Potak, H. T., Dhainaut, M., Mollaoglu, G., Park, M. D., et al. (2026) · Nature · doi:10.1038/s41586-026-11002-8

The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer

Schaefer, M. L., Tsai, S., & Blair, A. B. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-20366-0

Immunomodulatory impact of PTPN11 /SHP2-based vertical RAS-MAPK pathway inhibition in pancreatic cancerPreprint

Alrawashdeh, A. Y., Chen, X., Hafner, P., Keller, S. J., Das, T., Jumaa, H., Avery, T. Y., Besson, S., Hempel, S., Mewes, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.23.727401

Clinical Significance of a Cell‐Of‐Origin‐Based Classification in Pancreatic Ductal Adenocarcinoma

Kikuchi, T., Ako, S., Kato, H., Kinugasa, H., Uchida, M., Oda, T., Hirai, R., Matsumi, A., Miyamoto, K., Terasawa, H., et al. (2026) · Cancer Science · doi:10.1111/cas.70533

Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cellsPreprint

Hawthorne, K., Eng, J. R., Tsuda, M., Worth, P. J., Fields, A. J., Daniel, C. J., Nishida, A., Pelz, C., Langer, E. M., Waugh, T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.28.754674

Proteomic analysis of bioprinted pancreatic tumor models under different nutrient conditions

Buyuk, B., Li, M., Song, X., & Ye, K. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1921652

HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1αPreprint

Yamamoto, N., Dobersch, S., Robertson, T. M., Sim, J. H., Wallace-Povirk, A., Chew, N. W., Orellana, A. E., Aggrey-Fynn, J. E., Boila, L. D., Schutter, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.02.754697

Prognostic and Spatial Organization of Tertiary Lymphoid Structures in Pancreatic Ductal Adenocarcinoma

Jia, Y., Zhang, M., Yang, H., Shi, Y., & Zhang, S. (2026) · Biomedicines · doi:10.3390/biomedicines14102287

Super‐Resolution MRI–Derived Tumor‐Stroma Ratio Phenotyping for Prognostic and Therapeutic Stratification in Pancreatic Ductal Adenocarcinoma

Wang, X., Xie, Z., Li, H., Tang, Q., Zhou, J., Huang, J., 方世武, Li, D., Li, L., Zeng, M., et al. (2026) · MedComm · doi:10.1002/mco2.71039

Routine H&E Histology Encodes Postoperative Risk Heterogeneity in Resected Pancreatic Ductal Adenocarcinoma: A Multicohort Evaluation of TIGERS

Shen, Y., Chen, C., Jiang, H., Liu, W., Zhang, Y., Yang, Y., Yang, M., Zheng, D., Yu, J., Liu, F., et al. (2026) · Modern Pathology · doi:10.1016/j.modpat.2026.101099

BIMS-GA: Adaptive Multi-Objective Optimization for Network-Aware Pancreatic Ductal Adenocarcinoma Biomarker Discovery

Saeheaw, T. (2026) · Life · doi:10.3390/life16101716

KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer

Zhang, Y., Tang, S., Zhang, Y., Liu, J., Shi, X., Li, Y., Li, Y., Wang, H., Zhong, C., Sun, M., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.10.003

Tumor seudopapilar sólido del páncreas: presentación de un caso y revisión del tema

Leonher-Ruezga, K. L., Lopez-Espinosa, S., Herráiz, Á. M., Rojas, J. P., & López‐Andújar, R. (2013) · Cirugía Española · doi:10.1016/j.ciresp.2013.04.007 · Cited by 1

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Iacobuzio–Donahue, C. A., Hollingsworth, M. A., & Yeh, J. J. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/c139-w533

Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes

Zhao, L., Zhao, H., & Yan, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4546-8 · Cited by 93

Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes

de Santiago, I., Yau, C., Heij, L. R., Middleton, M. R., Markowetz, F. M., Grabsch, H. I., Dustin, M. L., & Sivakumar, S. (2019) · International Journal of Cancer · doi:10.1002/ijc.32186 · Cited by 50

Undiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC)

Ragulan, C., Poudel, P., Young, K., Nyamundanda, G., Lawlor, R. T., Scarpa, A., & Sadanandam, A. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx376.042